Torray Investment Partners LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 98758 Bethesda, MD

Position in AXSM

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$2,497,101

-$204,875 QoQ

Shares Held

14,774

-0.1% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.19453093271964.ToString("F0")% Shared 0.ToString("F0")% None 0.8054690672803573.ToString("F0")%

Healthcare · as of Mar 31, 2026

Torray Investment Partners LLC holds $54,354,232 across 8 Biotechnology names. AXSM ranks #5 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	645,425	$30,961,037
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,386	$6,870,464
3	BMRN	Biomarin Pharmaceutical Inc	78,170	$4,415,823
4	KRYS	Krystal Biotech, Inc.	12,032	$3,108,106
5	AXSM	Axsome Therapeutics, Inc. This page	14,774	$2,497,101
6	HALO	Halozyme Therapeutics, Inc.	38,179	$2,467,508
7	SNDX	Syndax Pharmaceuticals Inc	104,868	$2,449,716
8	VSTM	Verastem, Inc.	298,958	$1,584,477

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,497,101	14,774	-0.1%	Shares	Sole	2026-05-01
2025-12-31	$2,701,976	14,794	-15.1%	Shares	Sole	2026-01-28
2025-09-30	$2,115,537	17,419	+2.1%	Shares	Sole	2025-10-22
2025-06-30	$1,781,415	17,065	-0.3%	Shares	Sole	2025-08-05
2025-03-31	$1,996,239	17,116	-0.3%	Shares	Sole	2025-05-08
2024-12-31	$1,453,092	17,174	+45.3%	Shares	Sole	2025-02-06
2024-09-30	$1,062,533	11,823	+0.6%	Shares	Sole	2024-11-05
2024-06-30	$945,633	11,747	+11.5%	Shares	Sole	2024-08-06
2024-03-31	$840,932	10,538	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.